Corp-Ethics.com - Report: Pfizer to use DART for online campaigns

Company	Pfizer [Company Info]
	Track this Company (an email will be sent to you everytime a report is filed about this company)

Date	Issue	Title
26th Dec 2003	Questionable Practice	Pfizer to use DART for online campaigns

Report

NEW YORK, Jan. 8 /PRNewswire-FirstCall/ -- DoubleClick Inc. (Nasdaq: DCLK),
the leading provider of tools for advertisers, web publishers and direct
marketers today announced that Carat Interactive, a leading global media
agency, has agreed to exclusively use DoubleClick's ad management system,
DART(R) for Advertisers, on behalf of Pfizer Inc in order to deliver, report
on and measure its online marketing and advertising campaigns.
DART for Advertisers is DoubleClick's hosted, enterprise-class advertising
management and serving solution that helps marketers reach their online goals
efficiently and effectively.
"Carat Interactive has long used DoubleClick's DART for Advertisers
solution on behalf of many marketers, and it's with great confidence that we
recommended the system to Pfizer to increase the efficiency and effectiveness
of its online campaigns and to benefit from DoubleClick's insightful return-
on-investment reporting," said Angela Nguyen, Supervisor, Analysis Group,
Carat Interactive.
"We are clearly delighted that Pfizer, one of the world's best known
brands, will be serving and managing its online campaigns exclusively through
the DART system," said Doug Knopper, Senior Vice President & General Manager,
Advertiser & Publisher Solutions. "As more 'traditional' brands leverage the
Web as part of their marketing mix, DoubleClick is positioned to offer them a
best-of-breed ad management solution to make the online experience more
rewarding."
Additional information on the DFA product can be found at

Other Reports on Pfizer
Date	Issue	Company	Report
20th Jul 2007	Other Issue	Pfizer	Nigeria files new Pfizer claims
4th Apr 2007	Other Issue	Pfizer	Watchdog probes drug distribution
19th May 2004	Questionable Practice	Pfizer	Group sues Pfizer, other drug makers over imports
7th Jan 2004	Questionable Practice	Pfizer	Pfizer claims Britons denied treatment
4th Dec 2003	Questionable Practice	Pfizer	State Tax Report

Related Reports from the Pharamaceutical Industry
Company	Issue	Report
Merck	Other Issue	Split ruling in latest Vioxx case
Bristol-Myers Squibb	Fraud Investigation	Drugs firm settles fraud charges
Bayer	Fraud Investigation	$11.1 Million settlement
Merck	Other Issue	Vioxx drug ban hits Merck profits
GlaxoSmithKline	Other Issue	Glaxo shares dip on factory probe